Fmr LLC Senseonics Holdings, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Fmr LLC holds 348 shares of SENS stock, worth $153. This represents 0.0% of its overall portfolio holdings.

Number of Shares

348

Previous 119,041 99.71%

Holding current value

$153

Previous $63,000 100.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.37 - $0.52 $43,916 - $61,720	-118,693 Reduced 99.71%	348 $0
Q1 2024 May 13, 2024	SELL	$0.5 - $0.73 $34,123 - $49,820	-68,247 Reduced 36.44%	119,041 $63,000
Q4 2023 Feb 13, 2024	BUY	$0.48 - $0.7 $28,872 - $42,105	60,151 Added 47.31%	187,288 $106,000
Q3 2023 Nov 13, 2023	BUY	$0.5 - $1.05 $57,812 - $121,406	115,625 Added 1004.39%	127,137 $76,000
Q2 2023 Aug 11, 2023	BUY	$0.55 - $0.89 $3,894 - $6,301	7,080 Added 159.75%	11,512 $8,000
Q1 2023 May 11, 2023	SELL	$0.68 - $1.25 $2,225 - $4,091	-3,273 Reduced 42.48%	4,432 $3,000
Q4 2022 Feb 13, 2023	SELL	$0.96 - $1.34 $4,535 - $6,330	-4,724 Reduced 38.01%	7,705 $7,000
Q3 2022 Nov 10, 2022	BUY	$1.02 - $2.23 $7,864 - $17,193	7,710 Added 163.38%	12,429 $17,000
Q2 2022 Aug 12, 2022	BUY	$0.94 - $1.94 $2,953 - $6,095	3,142 Added 199.24%	4,719 $5,000
Q1 2022 May 13, 2022	BUY	$1.54 - $3.71 $2,428 - $5,850	1,577 New	1,577 $3,000
Q4 2021 Feb 14, 2022	SELL	$2.58 - $3.91 $12 - $19	-5 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.77 - $4.05 $4,160 - $6,083	-1,502 Reduced 99.67%	5 $0
Q2 2021 Aug 13, 2021	BUY	$1.71 - $4.14 $2,576 - $6,238	1,507 New	1,507 $5,000

Others Institutions Holding SENS

# of Institutions

141

Shares Held

59.5M

Call Options Held

413K

Put Options Held

212K

View Full List

About Senseonics Holdings, Inc.

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $205M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

More about SENS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account